Cargando…

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia

OBJECTIVE: To evaluate the long-term safety and efficacy of deutetrabenazine in patients with tardive dyskinesia (TD). METHOD: Patients with TD who completed the 12 week, phase 3, placebo-controlled trials were eligible to enter this open-label, single-arm study. The open-label study consisted of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez, Hubert H, Stamler, David, Davis, Mat D, Factor, Stewart A, Hauser, Robert A, Jimenez-Shahed, Joohi, Ondo, William G, Jarskog, L Fredrik, Woods, Scott W, Bega, Danny, LeDoux, Mark S, Shprecher, David R, Anderson, Karen E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Movement Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902058/ https://www.ncbi.nlm.nih.gov/pubmed/31296586 http://dx.doi.org/10.1136/jnnp-2018-319918

Ejemplares similares

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study
por: Fernandez, Hubert H., et al.
Publicado: (2017)

Deutetrabenazine in Tics Associated with Tourette Syndrome
por: Jankovic, Joseph, et al.
Publicado: (2016)

Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study
por: Hauser, Robert A., et al.
Publicado: (2022)

A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
por: Patel, Rikinkumar S., et al.
Publicado: (2019)

Psychiatric associations of adult-onset focal dystonia phenotypes
por: Berman, Brian D, et al.
Publicado: (2017)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Visual hallucinations in the differential diagnosis of parkinsonism
por: Bertram, Kelly, et al.
Publicado: (2012)

Clinical implications of early caudate dysfunction in Parkinson’s disease
por: Pasquini, Jacopo, et al.
Publicado: (2019)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
por: McGhee, David, et al.
Publicado: (2015)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

Effects of TPH2 gene variation and childhood trauma on the clinical and circuit-level phenotype of functional movement disorders
por: Spagnolo, Primavera A, et al.
Publicado: (2020)

The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
por: Rittman, Timothy, et al.
Publicado: (2013)

Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1
por: Tomlinson, Susan Elizabeth, et al.
Publicado: (2013)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease
por: Barker, Roger A, et al.
Publicado: (2013)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia
por: Becker, Esther B E, et al.
Publicado: (2012)

The differential diagnosis of Huntington's disease-like syndromes: ‘red flags’ for the clinician
por: Martino, Davide, et al.
Publicado: (2013)

The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
por: Klebe, Stephan, et al.
Publicado: (2013)

Bone health in Parkinson's disease: a systematic review and meta-analysis
por: Torsney, Kelli M, et al.
Publicado: (2014)

Fetal striatal grafting slows motor and cognitive decline of Huntington's disease
por: Paganini, Marco, et al.
Publicado: (2014)

Rest and other types of tremor in adult-onset primary dystonia
por: Erro, Roberto, et al.
Publicado: (2014)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
por: Dressler, Dirk, et al.
Publicado: (2013)

Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?
por: Doherty, Karen M, et al.
Publicado: (2013)

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
por: Noyce, Alastair J, et al.
Publicado: (2014)

REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease
por: Rolinski, Michal, et al.
Publicado: (2014)

Effect of subthalamic nucleus deep brain stimulation on dual-task cognitive and motor performance in isolated dystonia
por: Mills, Kelly A, et al.
Publicado: (2015)

Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach
por: Aviles-Olmos, Iciar, et al.
Publicado: (2014)

Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
por: Mochel, Fanny, et al.
Publicado: (2016)

Selective peripheral denervation for cervical dystonia: long-term follow-up
por: Bergenheim, A Tommy, et al.
Publicado: (2015)

Language Impairment in Adolescents with Sydenham Chorea
por: Millichap, J. Gordon
Publicado: (2015)

ADCY5 Mutations and Benign Hereditary Chorea
por: Millichap, J. Gordon
Publicado: (2015)

Risk of Tics with Psychostimulants for ADHD
por: Millichap, J. Gordon
Publicado: (2015)

Structural Connectivity in Gilles de la Tourette Syndrome
por: Chelse, Ana B., et al.
Publicado: (2015)

The prediagnostic phase of Parkinson's disease
por: Noyce, Alastair John, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6utrniisghqfavq6tja1sh521q